You are here

Article info

Article menu
Download PDFPDF
Aetiology/Harm
Cohort study
High-dose sulphonylurea treatment in patients with renal impairment should be considered with caution

Authors

  1. Correspondence to: Dr Eun Seok Kang, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea; edgo{at}yuhs.ac
View Full Text

Citation

Kim G, Kang ES
High-dose sulphonylurea treatment in patients with renal impairment should be considered with caution
BMJ Evidence-Based Medicine 2017;22:72.

Publication history

  • First published January 27, 2017.
Online issue publication 
March 23, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/